Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
EVP General Counsel and Secret
-
Stock Symbol
-
REGN on Nasdaq
Joseph Larosa - trading volume in the past year for Regeneron Pharmaceuticals, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
30.1K |
$22M |
$730.81 |
Dec 16, 2024 |
Direct |
|
|
Common Stock |
9K |
$6.58M |
$730.81 |
Dec 16, 2024 |
By 2024 GRAT |
|
|
Common Stock |
371 |
$271K |
$730.81 |
Dec 16, 2024 |
By 401(k) Plan |
|
|
Non-Qualified Stock Option (right to buy) |
14.5K |
|
|
Jun 24, 2024 |
Direct |
Common Stock |
|
Non-Qualified Stock Option (right to buy) |
8.98K |
|
|
Dec 6, 2024 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.